Catalog |
name |
Description |
price |
R-C-2686 |
Evofosfamide (TH-302) CAS:918633-87-1 |
Evofosfamide(TH-302)is a hypoxia-activated prodrug with IC50 of 10μM and 1000 μM in hypoxia(N2)and normoxia(21% O2),respectively. |
price> |
R-C-2750 |
Etomoxir CAS:124083-20-1 |
Etomoxir((R)-(+)-Etomoxir)is an irreversible inhibitor of carnitine palmitoyltransferase 1a(CPT-1a),inhibits fatty acid oxidation(FAO)through CPT-1a and inhibits palmitate β-oxidation in human,rat and guinea pig. |
price> |
R-R-4594 |
5-Fluorouridine CAS No.316-46-1 |
5-Fluorouridine/CAS No.316-46-1, a metabolite of 5-fluorouracil (HY-90006), is a potent ribozyme self-cleavage inhibitor. 5-Fluorouridine incorporates into both total and poly A RNA and has antiproliferative activity. 5-Fluorouridine induces apoptosis. |
price> |
R-R-4804 |
Methotrexate a-tert-butyl ester CAS No.79640-70-3 |
Methotrexate α-tert-butyl ester/CAS No.79640-70-3, capped by OtBu, significantly reduces tumor growth in HT1080 tumor bearing mice. Methotrexate is an antimetabolite and antifolate agent and is also an immunosuppressant and antineoplastic agent. |
price> |
R-R-4806 |
Polyinosinic-polycytidylic acid CAS No.24939-03-5 |
Polyinosinic-polycytidylic acid (Poly(I:C))/CAS No.24939-03-5 is a synthetic analog of double-stranded RNA and an agonist of toll-like receptor 3 (TLR3) and retinoic acid inducible gene I (RIG-I)-like receptors (RIG-I and MDA5). Polyinosinic-polycytidylic acid can be used as a vaccine adjuvant to enhance innate and adaptive immune responses, and to alter the tumor microenvironment. Polyinosinic-polycytidylic acid can directly trigger cancer cells to undergo apoptosis. |
price> |